EUVIMEDEUVIMED entdecken
Crossref

Vitamin D suppresses CD133+/CD44 + cancer stem cell stemness by inhibiting NF-κB signaling and reducing NLRP3 expression in triple-negative breast cancer

Wei Zheng, Wei Peng, Fuyong Qian, Mingshuai Zhang, Bofeng Duan, Zhifeng Fan, Yi Xie, Xiaoying Fu

Cancer Chemotherapy and Pharmacology · 2024

DOI: 10.1007/s00280-024-04660-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Wei Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, The Third People's Hospital of Shenzhen (The Second Affiliated Hospital of Southern University of Science a…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Signal Transduction, Triple Negative Breast Neoplasms, Vitamin D. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Project funded by Shenzhen Third People's Hospital, Project funded by Shenzhen Third People’s Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsSignal TransductionTriple Negative Breast NeoplasmsVitamin DAnimalsFemaleHumansMiceAC133 AntigenApoptosisCell Line, TumorCell ProliferationHyaluronan ReceptorsMice, Inbred BALB CMice, NudeNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Breast cancer stem cellNLRP3RXRαVitamin D

Substanzen

AC133 AntigenCD44 protein, humanHyaluronan ReceptorsNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanPROM1 protein, humanVitamin D

Autor:innen und Institutionen

  • Department of Thyroid and Breast Surgery, The Third People's Hospital of Shenzhen (The Second Affiliated Hospital of Southern University of Science and Technology), 29 Bulan Road, Longgang District, Shenzhen, Guangdong,…

Förderung

  • Project funded by Shenzhen Third People's Hospital
  • Project funded by Shenzhen Third People’s Hospital

Zitieren

APA

Zheng, W., Peng, W., Qian, F., Zhang, M., Duan, B., Fan, Z., Xie, Y., & Fu, X. (2024). Vitamin D suppresses CD133+/CD44 + cancer stem cell stemness by inhibiting NF-κB signaling and reducing NLRP3 expression in triple-negative breast cancer. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04660-w

Vancouver

Zheng W, Peng W, Qian F, Zhang M, Duan B, Fan Z, et al. Vitamin D suppresses CD133+/CD44 + cancer stem cell stemness by inhibiting NF-κB signaling and reducing NLRP3 expression in triple-negative breast cancer. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04660-w

BibTeX
@article{Zheng2024,
  author = {Zheng, Wei and Peng, Wei and Qian, Fuyong and Zhang, Mingshuai and Duan, Bofeng and Fan, Zhifeng and Xie, Yi and Fu, Xiaoying},
  title = {Vitamin D suppresses CD133+/CD44 + cancer stem cell stemness by inhibiting NF-κB signaling and reducing NLRP3 expression in triple-negative breast cancer},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2024},
  doi = {10.1007/s00280-024-04660-w}
}
Kostenlos starten →